메뉴 건너뛰기




Volumn 24, Issue 2, 2019, Pages

Polymyxin derivatives that sensitize Gram-negative bacteria to other antibiotics

Author keywords

Acinetobacter baumannii; Clinical phase 1 study; Enterobacteriaceae; NAB7061; Permeabilizers; Polymyxin B nonapeptide (PMBN); Pseudomonas aeruginosa; SPR741 NAB741; Synergism

Indexed keywords

ANTIINFECTIVE AGENT; POLYMYXIN;

EID: 85059895888     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules24020249     Document Type: Review
Times cited : (96)

References (116)
  • 1
    • 36849009383 scopus 로고
    • Aerosporin, an antibiotic produced by Bacillus aerosporus Greer
    • Ainsworth, G.C.; Brown, A.M.; Brownlee, G. Aerosporin, an antibiotic produced by Bacillus aerosporus Greer. Nature 1947, 160, 263. [CrossRef]
    • (1947) Nature , vol.160 , pp. 263
    • Ainsworth, G.C.1    Brown, A.M.2    Brownlee, G.3
  • 3
    • 0002004994 scopus 로고
    • Antibiotic activity of Bacillus polymyxa
    • Benedict, R.G.; Langlykke, A.F. Antibiotic activity of Bacillus polymyxa. J. Bacteriol. 1947, 54, 24–25. [PubMed]
    • (1947) J. Bacteriol. , vol.54 , pp. 24-25
    • Benedict, R.G.1    Langlykke, A.F.2
  • 4
    • 85059914026 scopus 로고
    • New wonder drug labeled polymyxin
    • 16 October
    • van Dellen, T.R. New wonder drug labeled polymyxin. The Spokesman-Review, 16 October 1948.
    • (1948) The Spokesman-Review
    • van Dellen, T.R.1
  • 9
    • 33748583751 scopus 로고    scopus 로고
    • Tigecycline: A glycylcycline antimicrobial agent
    • Doan, T.L.; Fung, F.B.; Mehta, D.; Riska, P.F. Tigecycline: A glycylcycline antimicrobial agent. Clin. Ther. 2006, 28, 1079–1106. [CrossRef]
    • (2006) Clin. Ther. , vol.28 , pp. 1079-1106
    • Doan, T.L.1    Fung, F.B.2    Mehta, D.3    Riska, P.F.4
  • 10
    • 84957433508 scopus 로고    scopus 로고
    • Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study
    • Liu, Y.Y.; Wang, Y.; Walsh, T.R.; Yi, L.X.; Zhang, R.; Spencer, J.; Doi, Y.; Tian, G.; Dong, B.; Huang, X.; et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis. 2016, 16, 161. [CrossRef]
    • (2016) Lancet Infect. Dis. , vol.16 , pp. 161
    • Liu, Y.Y.1    Wang, Y.2    Walsh, T.R.3    Yi, L.X.4    Zhang, R.5    Spencer, J.6    Doi, Y.7    Tian, G.8    Dong, B.9    Huang, X.10
  • 11
    • 84981717790 scopus 로고    scopus 로고
    • Molecular mechanisms of polymyxin resistance: Knowns and unknowns
    • Baron, S.; Hadjadj, L.; Rolain, J.M.; Olaitan, A.O. Molecular mechanisms of polymyxin resistance: Knowns and unknowns. Int. J. Antimicrob. Agents 2016, 48, 583–591. [CrossRef]
    • (2016) Int. J. Antimicrob. Agents , vol.48 , pp. 583-591
    • Baron, S.1    Hadjadj, L.2    Rolain, J.M.3    Olaitan, A.O.4
  • 12
    • 85012237142 scopus 로고    scopus 로고
    • Resistance to polymyxins in Gram-negative organisms
    • CrossRef PubMed
    • Jeannot, K.; Bolard, A.; Plésiat, P. Resistance to polymyxins in Gram-negative organisms. Int. J. Antimicrob. Agents 2017, 49, 526–535. [CrossRef] [PubMed]
    • (2017) Int. J. Antimicrob. Agents , vol.49 , pp. 526-535
    • Jeannot, K.1    Bolard, A.2    Plésiat, P.3
  • 13
    • 85016616771 scopus 로고    scopus 로고
    • Polymyxins: Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes
    • CrossRef PubMed
    • Poirel, L.; Jayol, A.; Nordmann, P. Polymyxins: Antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 2017, 30, 557–596. [CrossRef] [PubMed]
    • (2017) Clin. Microbiol. Rev. , vol.30 , pp. 557-596
    • Poirel, L.1    Jayol, A.2    Nordmann, P.3
  • 17
    • 0026802197 scopus 로고
    • Agents that increase the permeability of the outer membrane
    • Vaara, M. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 1992, 56, 395–401. [PubMed]
    • (1992) Microbiol. Rev. , vol.56 , pp. 395-401
    • Vaara, M.1
  • 18
    • 84880681078 scopus 로고    scopus 로고
    • Novel derivatives of polymyxins
    • CrossRef PubMed
    • Vaara, M. Novel derivatives of polymyxins. J. Antimicrob. Chemother. 2013, 68, 1213–1219. [CrossRef] [PubMed]
    • (2013) J. Antimicrob. Chemother. , vol.68 , pp. 1213-1219
    • Vaara, M.1
  • 19
    • 84879282675 scopus 로고
    • Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium
    • Vaara, M.; Vaara, T.; Jenssen, M.; Helander, I.; Nurminen, M.; Rietchel, E.T.; Mäkelä, P.H. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett. 1981, 29, 145–148. [CrossRef]
    • (1981) FEBS Lett , vol.29 , pp. 145-148
    • Vaara, M.1    Vaara, T.2    Jenssen, M.3    Helander, I.4    Nurminen, M.5    Rietchel, E.T.6    Mäkelä, P.H.7
  • 20
    • 85049866531 scopus 로고    scopus 로고
    • New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin and colistin
    • Vaara, M. New polymyxin derivatives that display improved efficacy in animal infection models as compared to polymyxin and colistin. Med. Res. Rev. 2018, 38, 1661–1673. [CrossRef]
    • (2018) Med. Res. Rev. , vol.38 , pp. 1661-1673
    • Vaara, M.1
  • 21
    • 85022178165 scopus 로고    scopus 로고
    • Recent advances and perspectives in the design and development of polymyxins
    • Rabanal, F.; Cajal, Y. Recent advances and perspectives in the design and development of polymyxins. Nat. Prod. Rep. 2017, 34, 886–908. [CrossRef]
    • (2017) Nat. Prod. Rep. , vol.34 , pp. 886-908
    • Rabanal, F.1    Cajal, Y.2
  • 22
    • 85016260606 scopus 로고    scopus 로고
    • Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections
    • Brown, P.; Dawson, M.J. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections. J. Antibiot. 2017, 70, 386–394. [CrossRef]
    • (2017) J. Antibiot. , vol.70 , pp. 386-394
    • Brown, P.1    Dawson, M.J.2
  • 23
    • 0040777048 scopus 로고    scopus 로고
    • The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: Studies on polymyxin B nonapeptide
    • Tsubery, H.; Ofek, I.; Cohen, S.; Fridkin, M. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: Studies on polymyxin B nonapeptide. Biochemistry 2000, 39, 11838–11844. [CrossRef]
    • (2000) Biochemistry , vol.39 , pp. 11838-11844
    • Tsubery, H.1    Ofek, I.2    Cohen, S.3    Fridkin, M.4
  • 24
    • 0020638314 scopus 로고
    • Sensitization of Gram-negative bacteria to antibiotics and complement by a non-toxic oligopeptide
    • CrossRef PubMed
    • Vaara, M.; Vaara, T. Sensitization of Gram-negative bacteria to antibiotics and complement by a non-toxic oligopeptide. Nature 1983, 303, 526–528. [CrossRef] [PubMed]
    • (1983) Nature , vol.303 , pp. 526-528
    • Vaara, M.1    Vaara, T.2
  • 25
    • 0020641094 scopus 로고
    • Polycations sensitize enteric bacteria to antibiotics
    • CrossRef PubMed
    • Vaara, M.; Vaara, T. Polycations sensitize enteric bacteria to antibiotics. Antimicrob. Agents Chemother. 1983, 24, 107–113. [CrossRef] [PubMed]
    • (1983) Antimicrob. Agents Chemother. , vol.24 , pp. 107-113
    • Vaara, M.1    Vaara, T.2
  • 26
    • 0028139998 scopus 로고
    • Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental Gram-negative infections in mice
    • CrossRef PubMed
    • Ofek, I.; Cohen, S.; Rahmani, R.; Kabha, K.; Herzig, Y.; Rubinstein, E. Antibacterial Synergism of Polymyxin B Nonapeptide and Hydrophobic Antibiotics in Experimental Gram-Negative Infections in Mice. Antimicrob. Agents Chemother. 1994, 38, 374–377. [CrossRef] [PubMed]
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 374-377
    • Ofek, I.1    Cohen, S.2    Rahmani, R.3    Kabha, K.4    Herzig, Y.5    Rubinstein, E.6
  • 30
    • 85059907568 scopus 로고    scopus 로고
    • Polymyxin B Nonapeptide is Nephrotoxic in Male Cynomolgus monkeys Following 7-Days Repeated Intravenous Dosing. Poster EV0304 22
    • Vienna, Austria, 22–25 April
    • Coleman, S.; Zabava, T.; Utley, L. Polymyxin B Nonapeptide is Nephrotoxic in Male Cynomolgus monkeys Following 7-Days Repeated Intravenous Dosing. Poster EV0304 22. In Proceedings of the ESCMID 2017, Vienna, Austria, 22–25 April 2017.
    • (2017) Proceedings of The ESCMID 2017
    • Coleman, S.1    Zabava, T.2    Utley, L.3
  • 31
    • 0027716710 scopus 로고
    • Mode of action of the depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic
    • Oliva, B.; Maiese, W.M.; Greenstein, M.; Borders, D.B.; Chopra, I. Mode of action of the depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. J. Antimicrob. Chemother. 1993, 32, 817–830. [CrossRef]
    • (1993) J. Antimicrob. Chemother. , vol.32 , pp. 817-830
    • Oliva, B.1    Maiese, W.M.2    Greenstein, M.3    Borders, D.B.4    Chopra, I.5
  • 33
    • 0032032992 scopus 로고    scopus 로고
    • Eradication of Acinetobacter baumannii by photosensitized agents in vitro
    • Nitzan, Y.; Balzam-Sudakevitz, A.; Ashkenazi, A. Eradication of Acinetobacter baumannii by photosensitized agents in vitro. J. Photochem. Photobiol. 1998, 42, 211–218. [CrossRef]
    • (1998) J. Photochem. Photobiol. , vol.42 , pp. 211-218
    • Nitzan, Y.1    Balzam-Sudakevitz, A.2    Ashkenazi, A.3
  • 37
    • 79954553031 scopus 로고    scopus 로고
    • Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels
    • CrossRef PubMed
    • Matsumoto, Y.; Hayama, K.; Sakakihara, S.; Nishino, K.; Noji, K.; Iino, R.; Yamaguchi, A. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS ONE 2011, 6, e18547. [CrossRef] [PubMed]
    • (2011) PLoS ONE , vol.6 , pp. e18547
    • Matsumoto, Y.1    Hayama, K.2    Sakakihara, S.3    Nishino, K.4    Noji, K.5    Iino, R.6    Yamaguchi, A.7
  • 38
    • 84897420865 scopus 로고    scopus 로고
    • Development of 4H-pyridopyrimides: A class of selective bacterial protein synthesis inhibitors
    • CrossRef PubMed
    • Guiles, J.W.; Toro, A.; Ochsner, U.A.; Bullard, J.M. Development of 4H-pyridopyrimides: A class of selective bacterial protein synthesis inhibitors. Org. Med. Chem. Lett. 2012, 2, 5. [CrossRef] [PubMed]
    • (2012) Org. Med. Chem. Lett. , vol.2 , pp. 5
    • Guiles, J.W.1    Toro, A.2    Ochsner, U.A.3    Bullard, J.M.4
  • 39
    • 84900322618 scopus 로고    scopus 로고
    • Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I
    • CrossRef PubMed
    • Duan, F.; Li, X.; Cai, S.; Xin, G.; Wang, Y.; Du, D.; He, S.; Huang, B.; Guo, X.; Zhao, R.; et al. Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I. J. Med. Chem. 2014, 57, 3707–3714. [CrossRef] [PubMed]
    • (2014) J. Med. Chem. , vol.57 , pp. 3707-3714
    • Duan, F.1    Li, X.2    Cai, S.3    Xin, G.4    Wang, Y.5    Du, D.6    He, S.7    Huang, B.8    Guo, X.9    Zhao, R.10
  • 40
    • 84899073270 scopus 로고    scopus 로고
    • The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. Coli is improved by combination with miconazole and polymyxin B nonapeptide
    • Sahlberg Bang, C.; Kinnunen, A.; Karlsson, M.; Önnberg, A.; Söderquist, B.; Persson, K. The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide. BMC Microbiol. 2014, 14, 65. [CrossRef]
    • (2014) BMC Microbiol , vol.14 , pp. 65
    • Sahlberg Bang, C.1    Kinnunen, A.2    Karlsson, M.3    Önnberg, A.4    Söderquist, B.5    Persson, K.6
  • 41
    • 84960156283 scopus 로고    scopus 로고
    • Role of the outer membrane and porins in susceptibility of β-lactamase-producing Enterobacteriaceae to ceftazidime-avibactam
    • Pagès, J.-M.; Peslier, S.; Keating, T.A.; Lavigne, J.-P.; Nichols, W.W. Role of the outer membrane and porins in susceptibility of β-lactamase-producing Enterobacteriaceae to ceftazidime-avibactam. Antimicrob. Agents Chemother. 2015, 60, 1349–1359. [CrossRef]
    • (2015) Antimicrob. Agents Chemother. , vol.60 , pp. 1349-1359
    • Pagès, J.-M.1    Peslier, S.2    Keating, T.A.3    Lavigne, J.-P.4    Nichols, W.W.5
  • 42
    • 84991773666 scopus 로고    scopus 로고
    • Using chemical probes to assess the feasibility of targeting SecA for developing antimicrobial agents against Gram-negative bacteria
    • Jin, J.; Hsieh, Y.-H.; Cui, J.; Damera, K.; Dai, C.; Chaudhary, A.S.; Zhang, H.; Yang, H.; Cao, N.; Jiang, C.; et al. Using chemical probes to assess the feasibility of targeting SecA for developing antimicrobial agents against Gram-negative bacteria. Chem. Med. Chem. 2016, 11, 2511–2521. [CrossRef]
    • (2016) Chem. Med. Chem. , vol.11 , pp. 2511-2521
    • Jin, J.1    Hsieh, Y.-H.2    Cui, J.3    Damera, K.4    Dai, C.5    Chaudhary, A.S.6    Zhang, H.7    Yang, H.8    Cao, N.9    Jiang, C.10
  • 44
    • 85042735090 scopus 로고    scopus 로고
    • Lipoprotein signal peptidase inhibitors with antibiotics properties identified trough design of a robust in vitro HT plasform
    • Kitamura, S.; Owensby, A.; Wall, D.; Wolan, D.W. Lipoprotein signal peptidase inhibitors with antibiotics properties identified trough design of a robust in vitro HT plasform. Cell Chem. Biol. 2018, 25, 301–308. [CrossRef]
    • (2018) Cell Chem. Biol. , vol.25 , pp. 301-308
    • Kitamura, S.1    Owensby, A.2    Wall, D.3    Wolan, D.W.4
  • 45
    • 85054084779 scopus 로고    scopus 로고
    • Synthesis of 1,2,3-triazole linked 4(3H)-quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus
    • CrossRef PubMed
    • Gatadi, S.; Gour, J.; Shukla, M.; Kaul, G.; Das, S.; Dasgupta, A.; Malasala, S.; Borra, R.S.; Madhavi, Y.V.; Chopra, S.; et al. Synthesis of 1,2,3-triazole linked 4(3H)-quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus. Eur. J. Med. Chem. 2018, 157, 1056–1067. [CrossRef] [PubMed]
    • (2018) Eur. J. Med. Chem. , vol.157 , pp. 1056-1067
    • Gatadi, S.1    Gour, J.2    Shukla, M.3    Kaul, G.4    Das, S.5    Dasgupta, A.6    Malasala, S.7    Borra, R.S.8    Madhavi, Y.V.9    Chopra, S.10
  • 48
    • 0033546193 scopus 로고    scopus 로고
    • A novel labeling approach supports the five-transmembrane model of subunit α of the Escherichia coli ATP synthase
    • CrossRef PubMed
    • Wada, T.; Long, J.C.; Zhang, D.; Vik, S.B. A novel labeling approach supports the five-transmembrane model of subunit α of the Escherichia coli ATP synthase. J. Biol. Chem. 1999, 274, 17353–17357. [CrossRef] [PubMed]
    • (1999) J. Biol. Chem. , vol.274 , pp. 17353-17357
    • Wada, T.1    Long, J.C.2    Zhang, D.3    Vik, S.B.4
  • 49
    • 0036840644 scopus 로고    scopus 로고
    • Regulated expression of the Escherichia coli lepB gene as a tool for cellular testing of antimicrobial compounds that inhibit signal peptidase I in vitro
    • CrossRef PubMed
    • Barbosa, M.D.; Lin, S.; Markwalder, J.A.; Mills, J.A.; DeVito, J.A.; Teleha, C.A.; Carlapati, V.; Thompson, A.; Trainor, G.L. Regulated expression of the Escherichia coli lepB gene as a tool for cellular testing of antimicrobial compounds that inhibit signal peptidase I in vitro. Antimicrob. Agents Chemother. 2002, 46, 3549–3554. [CrossRef] [PubMed]
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 3549-3554
    • Barbosa, M.D.1    Lin, S.2    Markwalder, J.A.3    Mills, J.A.4    DeVito, J.A.5    Teleha, C.A.6    Carlapati, V.7    Thompson, A.8    Trainor, G.L.9
  • 50
    • 4444327370 scopus 로고    scopus 로고
    • Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes
    • CrossRef PubMed
    • Longbottom, C.J.; Carson, C.F.; Hammer, K.A.; Mee, B.J.; Riley, T.V. Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. J. Antimicrob. Chemother. 2004, 54, 386–392. [CrossRef] [PubMed]
    • (2004) J. Antimicrob. Chemother. , vol.54 , pp. 386-392
    • Longbottom, C.J.1    Carson, C.F.2    Hammer, K.A.3    Mee, B.J.4    Riley, T.V.5
  • 51
    • 22544466136 scopus 로고    scopus 로고
    • Effect of outer membrane permeabilization on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa
    • Champlin, F.R.; Ellison, M.L.; Bullard, J.W.; Conrad, R.S. Effect of outer membrane permeabilization on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 2005, 26, 159–164. [CrossRef]
    • (2005) Int. J. Antimicrob. Agents , vol.26 , pp. 159-164
    • Champlin, F.R.1    Ellison, M.L.2    Bullard, J.W.3    Conrad, R.S.4
  • 52
    • 57449106309 scopus 로고    scopus 로고
    • Protochlorophyllide: A new photosensitizer for the photodynamic inactivation of Gram-positive and Gram-negative bacteria
    • Walther, J.; Bröcker, M.J.; Wätzlich, D.; Nimtz, M.; Rohde, M.; Jahn, D.; Moser, J. Protochlorophyllide: A new photosensitizer for the photodynamic inactivation of Gram-positive and Gram-negative bacteria. FEMS Microbiol. Lett. 2009, 290, 156–163. [CrossRef]
    • (2009) FEMS Microbiol. Lett. , vol.290 , pp. 156-163
    • Walther, J.1    Bröcker, M.J.2    Wätzlich, D.3    Nimtz, M.4    Rohde, M.5    Jahn, D.6    Moser, J.7
  • 53
    • 84937010356 scopus 로고    scopus 로고
    • Importance of real-time assays to distinguish multidrug efflux pump-inhibiting and outer membrane-destabilizing activities in Escherichia coli
    • Misra, R.; Morrison, K.D.; Cho, H.J.; Khuu, T. Importance of real-time assays to distinguish multidrug efflux pump-inhibiting and outer membrane-destabilizing activities in Escherichia coli. J. Bacteriol. 2015, 197, 2479–2488. [CrossRef]
    • (2015) J. Bacteriol. , vol.197 , pp. 2479-2488
    • Misra, R.1    Morrison, K.D.2    Cho, H.J.3    Khuu, T.4
  • 54
    • 85018489873 scopus 로고    scopus 로고
    • A fluorescent probe distinguishes between inhibition of early and late steps of lipopolysaccharide biogenesis in whole cells
    • Moison, E.; Xie, R.; Zhang, G.; Lebar, M.D.; Meredith, T.C.; Kahne, D. A fluorescent probe distinguishes between inhibition of early and late steps of lipopolysaccharide biogenesis in whole cells. ACS Chem. Biol. 2017, 12, 928–932. [CrossRef]
    • (2017) ACS Chem. Biol. , vol.12 , pp. 928-932
    • Moison, E.1    Xie, R.2    Zhang, G.3    Lebar, M.D.4    Meredith, T.C.5    Kahne, D.6
  • 56
    • 77953706297 scopus 로고    scopus 로고
    • Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin
    • CrossRef PubMed
    • Vaara, M.; Siikanen, O.; Apajalahti, J.; Frimodt-Möller, N.; Vaara, T. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin. J. Antimicrob. Chemother. 2010, 65, 942–945. [CrossRef] [PubMed]
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 942-945
    • Vaara, M.1    Siikanen, O.2    Apajalahti, J.3    Frimodt-Möller, N.4    Vaara, T.5
  • 57
    • 77953707737 scopus 로고    scopus 로고
    • Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice
    • CrossRef PubMed
    • Vingsbo Lundberg, C.; Vaara, T.; Frimodt-Möller, N.; Vaara, M. Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice. J. Antimicrob. Chemother. 2010, 65, 981–985. [CrossRef] [PubMed]
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 981-985
    • Vingsbo Lundberg, C.1    Vaara, T.2    Frimodt-Möller, N.3    Vaara, M.4
  • 58
    • 73949154997 scopus 로고    scopus 로고
    • Pharmacokinetics of novel antimicrobial cationic peptides NAB7061 and NAB739 in rats following intravenous administration
    • CrossRef PubMed
    • Ali, F.E.; Cao, G.; Poydal, A.; Vaara, T.; Nation, R.L.; Vaara, M.; Li, J. Pharmacokinetics of novel antimicrobial cationic peptides NAB7061 and NAB739 in rats following intravenous administration. J Antimicrob. Chemother. 2009, 64, 1067–1070. [CrossRef] [PubMed]
    • (2009) J Antimicrob. Chemother. , vol.64 , pp. 1067-1070
    • Ali, F.E.1    Cao, G.2    Poydal, A.3    Vaara, T.4    Nation, R.L.5    Vaara, M.6    Li, J.7
  • 59
    • 78049464981 scopus 로고    scopus 로고
    • Structure-activity studies on novel polymyxin derivatives that carry only three positive charges
    • CrossRef PubMed
    • Vaara, M.; Vaara, T. Structure-activity studies on novel polymyxin derivatives that carry only three positive charges. Peptides 2010, 31, 2318–2321. [CrossRef] [PubMed]
    • (2010) Peptides , vol.31 , pp. 2318-2321
    • Vaara, M.1    Vaara, T.2
  • 60
    • 77955345521 scopus 로고    scopus 로고
    • A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane
    • CrossRef PubMed
    • Vaara, M.; Siikanen, O.; Apajalahti, J.; Fox, J.; Frimodt-Møller, N.; He, H.; Poydal, A.; Li, J.; Nation, R.L.; Vaara, T. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob. Agents Chemother. 2010, 54, 3341–3346. [CrossRef] [PubMed]
    • (2010) Antimicrob. Agents Chemother. , vol.54 , pp. 3341-3346
    • Vaara, M.1    Siikanen, O.2    Apajalahti, J.3    Fox, J.4    Frimodt-Møller, N.5    He, H.6    Poydal, A.7    Li, J.8    Nation, R.L.9    Vaara, T.10
  • 61
    • 85059884775 scopus 로고    scopus 로고
    • Available online: accessed on 10 January 2019
    • Spero Therapeutics: Spero Therapeutics announces positive phase 1 clinical data. Available online: https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-announces-positive-phase-1-clinical-data (accessed on 10 January 2019).
    • Spero Therapeutics: Spero Therapeutics Announces Positive Phase 1 Clinical Data
  • 67
    • 85052613735 scopus 로고    scopus 로고
    • Lefamulin: Review of a promising novel pleuromutilin antibiotic
    • Veve, M.P.; Wagner, J.L. Lefamulin: Review of a promising novel pleuromutilin antibiotic. Pharmacotherapy 2018, 38, 935–946. [CrossRef]
    • (2018) Pharmacotherapy , vol.38 , pp. 935-946
    • Veve, M.P.1    Wagner, J.L.2
  • 68
    • 85059894800 scopus 로고    scopus 로고
    • Available online: accessed on 10 January 2019
    • Nabriva: Our goal is to develop new antibiotics. Available online: https://www.nabriva.com/pipeline-research (accessed on 10 January 2019).
    • Nabriva: Our Goal Is to Develop New Antibiotics
  • 69
    • 85059885952 scopus 로고    scopus 로고
    • In vitro activity of SPR741 against recent clinical isolates of Escherichia coli and Klebsiella pneumoniae. Poster Saturday-500
    • Boston, CA, USA, 16–20 June
    • Hackel, M.; Lister, T.; Parr, T.R., Jr.; Sahm, D. In vitro activity of SPR741 against recent clinical isolates of Escherichia coli and Klebsiella pneumoniae. Poster Saturday-500. In Proceedings of the ASM Microbe 2016—American Society for Microbiology Conference, Boston, CA, USA, 16–20 June 2016.
    • (2016) Proceedings of The ASM Microbe 2016—American Society for Microbiology Conference
    • Hackel, M.1    Lister, T.2    Parr, T.R.3    Sahm, D.4
  • 71
    • 85059895061 scopus 로고    scopus 로고
    • Potentiation of clarithromycin when combined with a new cationic peptide against Gram-negative clinical isolates and molecular analysis of macrolide resistance by next-generation sequencing. Poster Sunday-162
    • New Orleans, LA, USA, 1–5 June
    • Mendes, R.E.; Rhomberg, P.R.; Becker, H.K.; Davis, A.P.; Lister, T.; Lee, A.; Parr, T.R., Jr.; Vaara, M.; Flamm, R.K. Potentiation of clarithromycin when combined with a new cationic peptide against Gram-negative clinical isolates and molecular analysis of macrolide resistance by next-generation sequencing. Poster Sunday-162. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Mendes, R.E.1    Rhomberg, P.R.2    Becker, H.K.3    Davis, A.P.4    Lister, T.5    Lee, A.6    Parr, T.R.7    Vaara, M.8    Flamm, R.K.9
  • 72
    • 85034748136 scopus 로고    scopus 로고
    • SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii
    • Zurawski, D.Y.; Reinhart, A.A.; Alamneh, Y.A.; Pucci, M.J.; Si, Y.; Abu-Taleb, R.; Shearer, J.P.; Demons, S.T.; Tyner, S.D.; Lister, T. SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2017, 61, e01239-17. [CrossRef]
    • (2017) Antimicrob. Agents Chemother. , vol.61 , pp. e01239-e01317
    • Zurawski, D.Y.1    Reinhart, A.A.2    Alamneh, Y.A.3    Pucci, M.J.4    Si, Y.5    Abu-Taleb, R.6    Shearer, J.P.7    Demons, S.T.8    Tyner, S.D.9    Lister, T.10
  • 74
    • 85059892947 scopus 로고    scopus 로고
    • Bactericidal activity of piperacillin-tazobactam in combination with SPR741 against susceptible, extended-spectrum beta-lactamase producing, and multidrug resistant Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Poster P1675
    • Madrid, Spain, 21–24 April
    • Zou, Y.; Cotroneo, N.; Lister, T.; Rubio, A. Bactericidal activity of piperacillin-tazobactam in combination with SPR741 against susceptible, extended-spectrum beta-lactamase producing, and multidrug resistant Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Poster P1675. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Zou, Y.1    Cotroneo, N.2    Lister, T.3    Rubio, A.4
  • 75
    • 85059887073 scopus 로고    scopus 로고
    • Antimicrobial activity of ceftazidime and piperacillin-tazobactam tested in combination with a potentiator molecule (SPR741) against Enterobacteriaceae causing urinary tract infections. Poster P1671
    • Madrid, Spain, 21–24 April
    • Mendes, R.E.; Rhomberg, P.R.; Lister, T.; Cotroneo, N.; Rubio, A.; Flamm, R.K. Antimicrobial activity of ceftazidime and piperacillin-tazobactam tested in combination with a potentiator molecule (SPR741) against Enterobacteriaceae causing urinary tract infections. Poster P1671. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Mendes, R.E.1    Rhomberg, P.R.2    Lister, T.3    Cotroneo, N.4    Rubio, A.5    Flamm, R.K.6
  • 76
    • 85059892947 scopus 로고    scopus 로고
    • Bactericidal activity of ceftazidime in combination with SPR741 against susceptible, extended-spectrum betalactamase-producing, and multidrug resistant Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Poster P1674
    • Madrid, Spain, 21–24 April
    • Zou, Y.; Cotroneo, N.; Lister, T.; Rubio, A. Bactericidal activity of ceftazidime in combination with SPR741 against susceptible, extended-spectrum betalactamase-producing, and multidrug resistant Escherichia coli, Klebsiella pneumoniae, and Enterobacter species. Poster P1674. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Zou, Y.1    Cotroneo, N.2    Lister, T.3    Rubio, A.4
  • 77
    • 85059887073 scopus 로고    scopus 로고
    • Evaluation of synergistic effects of a potentiator molecule (SPR741) when tested in combination with a series of β-lactam agents against a challenge set of Gram-negative pathogens. Poster P1672
    • Madrid, Spain, 21–24 April
    • Mendes, R.E.; Rhomberg, P.R.; Lister, T.; Cotroneo, N.; Rubio, A.; Flamm, R.K. Evaluation of synergistic effects of a potentiator molecule (SPR741) when tested in combination with a series of β-lactam agents against a challenge set of Gram-negative pathogens. Poster P1672. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Mendes, R.E.1    Rhomberg, P.R.2    Lister, T.3    Cotroneo, N.4    Rubio, A.5    Flamm, R.K.6
  • 78
    • 85059908777 scopus 로고    scopus 로고
    • In vitro activity of ceftazidime alone and in combination with SPR741 against anaerobic bacteria. Poster P1673
    • Madrid, Spain, 21–24 April
    • Citron, D.M.; Tyrrell, K.L.; Rubio, A.; Goldstein, E.J. In vitro activity of ceftazidime alone and in combination with SPR741 against anaerobic bacteria. Poster P1673. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Citron, D.M.1    Tyrrell, K.L.2    Rubio, A.3    Goldstein, E.J.4
  • 81
    • 85059903503 scopus 로고    scopus 로고
    • Synergistic effect of novel gyrase inhibitor agents (SPR750 and SPR751) in combination with a polymyxin derivative (SPR741) against recent Acinetobacter baumannii and Enterobacteriaceae. Poster Sunday-13
    • New Orleans, LA, USA, 1–5 June
    • Mendes, R.E.; Rhomberg, P.R.; Edah, Y.; Lister, T.; Parr, T.R., Jr.; Vaara, M.; Flamm, R.K. Synergistic effect of novel gyrase inhibitor agents (SPR750 and SPR751) in combination with a polymyxin derivative (SPR741) against recent Acinetobacter baumannii and Enterobacteriaceae. Poster Sunday-13. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Mendes, R.E.1    Rhomberg, P.R.2    Edah, Y.3    Lister, T.4    Parr, T.R.5    Vaara, M.6    Flamm, R.K.7
  • 82
    • 85059895941 scopus 로고    scopus 로고
    • In vitro activity of SPR741 combined with three novel compounds against recent clinical isolates of Acinetobacter baumannii and Enterobacteriaceae. Poster Sunday-27
    • New Orleans, LA, USA, 1–5 June
    • Hackel, M.; Lister, T.; Parr, T.R., Jr.; Vaara, M.; Sahm, D. In vitro activity of SPR741 combined with three novel compounds against recent clinical isolates of Acinetobacter baumannii and Enterobacteriaceae. Poster Sunday-27. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Hackel, M.1    Lister, T.2    Parr, T.R.3    Vaara, M.4    Sahm, D.5
  • 83
    • 85059903503 scopus 로고    scopus 로고
    • Antimicrobial synergistic effect of a new anti-Gram-positive agents tested in combination with a polymyxin derivative against Gram-negative pathogens, including ESKAPE group organisms. Poster Sunday-23
    • New Orleans, LA, USA, 1–5 June
    • Mendes, R.E.; Rhomberg, P.R.; Lee, A.; Lister, T.; Parr, T.R., Jr.; Vaara, M.; Flamm, R.K. Antimicrobial synergistic effect of a new anti-Gram-positive agents tested in combination with a polymyxin derivative against Gram-negative pathogens, including ESKAPE group organisms. Poster Sunday-23. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Mendes, R.E.1    Rhomberg, P.R.2    Lee, A.3    Lister, T.4    Parr, T.R.5    Vaara, M.6    Flamm, R.K.7
  • 84
    • 85058724679 scopus 로고    scopus 로고
    • Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: Synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
    • Brunati, C.; Thomsen, T.T.; Gaspari, E.; Maffiolo, S.; Sosio, M.; Jabes, D.; Løbner-Olelen, A.; Donaldo, S. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: Synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. J. Antimicrob. Chemother. 2018, 73, 414–424. [CrossRef]
    • (2018) J. Antimicrob. Chemother. , vol.73 , pp. 414-424
    • Brunati, C.1    Thomsen, T.T.2    Gaspari, E.3    Maffiolo, S.4    Sosio, M.5    Jabes, D.6    Løbner-Olelen, A.7    Donaldo, S.8
  • 85
    • 0026570820 scopus 로고
    • Uptake of minocycline by Escherichia coli
    • Chopra, I.; Hacker, K. Uptake of minocycline by Escherichia coli. J. Antimicrob. Chemother. 1992, 29, 19–25. [CrossRef]
    • (1992) J. Antimicrob. Chemother. , vol.29 , pp. 19-25
    • Chopra, I.1    Hacker, K.2
  • 86
    • 85059895393 scopus 로고    scopus 로고
    • In vivo efficacy of combinations of novel antimicrobial peptide SPR741 and rifampin in a K. Pneumoniae murine model of urinary tract infection. Poster Saturday-249
    • New Orleans, LA, USA, 1–5 June
    • Rubio, A.; Weiss, W.J.; Pulse, M.; Lister, T.; Parr, T.R., Jr. In vivo efficacy of combinations of novel antimicrobial peptide SPR741 and rifampin in a K. pneumoniae murine model of urinary tract infection. Poster Saturday-249. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Rubio, A.1    Weiss, W.J.2    Pulse, M.3    Lister, T.4    Parr, T.R.5
  • 87
    • 85059892788 scopus 로고    scopus 로고
    • Efficacy of novel cationic peptide SPR741 and gyrase inhibitor SPR720 combinations against carbapenem-resistant K. Pneumoniae in a murine UTI model. Poster Saturday-259
    • New Orleans, LA, USA, 1–5 June
    • Weiss, W.J.; Pulse, M.; Nguyen, P.; Parr, T.R., Jr.; Lister, T.; Rubio, A. Efficacy of novel cationic peptide SPR741 and gyrase inhibitor SPR720 combinations against carbapenem-resistant K. pneumoniae in a murine UTI model. Poster Saturday-259. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Weiss, W.J.1    Pulse, M.2    Nguyen, P.3    Parr, T.R.4    Lister, T.5    Rubio, A.6
  • 88
    • 85044237591 scopus 로고    scopus 로고
    • In vivo efficacy of combinations of novel antimicrobial cationic peptide SPR741 and clarithromycin in short-duration murine thigh and lung models of Gram-negative infection. Poster Saturday-498
    • Boston, CA, USA, 16–20 June
    • Warn, P.; Sattar, A.; Thommes, P.; Corbett, D.; Holden, K.; Lister, T.; Parr, T.R., Jr. In vivo efficacy of combinations of novel antimicrobial cationic peptide SPR741 and clarithromycin in short-duration murine thigh and lung models of Gram-negative infection. Poster Saturday-498. In Proceedings of the ASM Microbe 2016—American Society for Microbiology Conference, Boston, CA, USA, 16–20 June 2016.
    • (2016) Proceedings of The ASM Microbe 2016—American Society for Microbiology Conference
    • Warn, P.1    Sattar, A.2    Thommes, P.3    Corbett, D.4    Holden, K.5    Lister, T.6    Parr, T.R.7
  • 89
    • 85049054209 scopus 로고    scopus 로고
    • Assessment of the in vivo activity of SPR741 in combination with azithromycin against multidrug-resistant Enterobacteriaceae isolates in the neutropenic murine thigh infection model
    • CrossRef PubMed
    • Stainton, S.M.; Abdelraouf, K.; Utley, L.; Pucci, M.; Lister, T.; Nicolau, D.P. Assessment of the in vivo activity of SPR741 in combination with azithromycin against multidrug-resistant Enterobacteriaceae isolates in the neutropenic murine thigh infection model. Antimicrob. Agents Chemother. 2018, 62, e00239-18. [CrossRef] [PubMed]
    • (2018) Antimicrob. Agents Chemother. , vol.62 , pp. e00239-e00318
    • Stainton, S.M.1    Abdelraouf, K.2    Utley, L.3    Pucci, M.4    Lister, T.5    Nicolau, D.P.6
  • 90
    • 85059912620 scopus 로고    scopus 로고
    • Impact of dosing regimens on the in vivo efficacy of combinations of novel antimicrobial cationic peptide SPR741 and rifampicin in murine thigh infection models. Poster Saturday-496
    • Boston, CA, USA, 16–20 June
    • Warn, P.; Corbett, D.; Gould, J.; Parker, G.; Daws, G.; Thommes, P.; Lister, T.; Parr, T.R., Jr. Impact of dosing regimens on the in vivo efficacy of combinations of novel antimicrobial cationic peptide SPR741 and rifampicin in murine thigh infection models. Poster Saturday-496. In Proceedings of the ASM Microbe 2016—American Society for Microbiology Conference, Boston, CA, USA, 16–20 June 2016.
    • (2016) Proceedings of The ASM Microbe 2016—American Society for Microbiology Conference
    • Warn, P.1    Corbett, D.2    Gould, J.3    Parker, G.4    Daws, G.5    Thommes, P.6    Lister, T.7    Parr, T.R.8
  • 91
    • 85044237591 scopus 로고    scopus 로고
    • In vivo efficacy of combinations of novel antimicrobial peptide SPR741 and rifampicin in short-duration murine thigh infection models of Gram-negative bacterial infection. Poster Monday-561
    • Boston, CA, USA, 16–20 June
    • Warn, P.; Thommes, P.; Vaddi, S.; Corbett, D.; Coles, D.; Vaccaro, L.; Lister, T.; Parr, T.R., Jr. In vivo efficacy of combinations of novel antimicrobial peptide SPR741 and rifampicin in short-duration murine thigh infection models of Gram-negative bacterial infection. Poster Monday-561. In Proceedings of the ASM Microbe 2016—American Society for Microbiology Conference, Boston, CA, USA, 16–20 June 2016.
    • (2016) Proceedings of The ASM Microbe 2016—American Society for Microbiology Conference
    • Warn, P.1    Thommes, P.2    Vaddi, S.3    Corbett, D.4    Coles, D.5    Vaccaro, L.6    Lister, T.7    Parr, T.R.8
  • 93
    • 84861197029 scopus 로고    scopus 로고
    • Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells
    • CrossRef PubMed
    • Mingeot-Leclerq, M.P.; Tulkens, P.M.; Denamur, S.; Vaara, T.; Vaara, M. Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells. Peptides 2012, 35, 248–252. [CrossRef] [PubMed]
    • (2012) Peptides , vol.35 , pp. 248-252
    • Mingeot-Leclerq, M.P.1    Tulkens, P.M.2    Denamur, S.3    Vaara, T.4    Vaara, M.5
  • 97
    • 85059900758 scopus 로고    scopus 로고
    • Pharmacokinetics of SPR741 in rats and non-human primates after a one hour intravenous infusion. Poster Saturday-247
    • New Orleans, LA, USA, 1–5 June
    • Utley, L.; Coleman, S. Pharmacokinetics of SPR741 in rats and non-human primates after a one hour intravenous infusion. Poster Saturday-247. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Utley, L.1    Coleman, S.2
  • 98
    • 85059885017 scopus 로고    scopus 로고
    • SPR741 GLP safety pharmacology studies across cardiac, pulmonary and central nervous systems. Poster Saturday-252
    • New Orleans, LA, USA, 1–5 June
    • Coleman, S.; Bleavins, M. SPR741 GLP safety pharmacology studies across cardiac, pulmonary and central nervous systems. Poster Saturday-252. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Coleman, S.1    Bleavins, M.2
  • 99
    • 85059885017 scopus 로고    scopus 로고
    • SPR741 is non-genotoxic in the ICH battery of GLP Ames, chromosomal aberration, in in vivo micronucleus studies. Poster Saturday-253
    • New Orleans, LA, USA, 1–5 June
    • Coleman, S.; Bleavins, M. SPR741 is non-genotoxic in the ICH battery of GLP Ames, chromosomal aberration, in in vivo micronucleus studies. Poster Saturday-253. In Proceedings of the ASM Microbe 2017—American Society for Microbiology Conference, New Orleans, LA, USA, 1–5 June 2017.
    • (2017) Proceedings of The ASM Microbe 2017—American Society for Microbiology Conference
    • Coleman, S.1    Bleavins, M.2
  • 101
    • 85059882123 scopus 로고    scopus 로고
    • Safety of SPR741, a novel polymyxin potentiator, in healthy adults receiving single- And multiple-dose intravenous administrations. Poster P2206
    • Madrid, Spain, 21–24 April
    • Eckburg, P.B.; Farinola, N.; Utley, L.; Walpole, S.; Keutzer, T.; Kopp, E.; Coleman, S.; Tomayko, J. Safety of SPR741, a novel polymyxin potentiator, in healthy adults receiving single- and multiple-dose intravenous administrations. Poster P2206. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Eckburg, P.B.1    Farinola, N.2    Utley, L.3    Walpole, S.4    Keutzer, T.5    Kopp, E.6    Coleman, S.7    Tomayko, J.8
  • 102
    • 85059913799 scopus 로고    scopus 로고
    • Determination of the pharmacokinetics of single (SAD) and multiple ascending doses (MAD) of SPR741 in healthy volunteers. Poster P2233
    • Madrid, Spain, 21–24 April
    • Utley, L.; Lister, T.; Coleman, S.; Eckburg, P.B. Determination of the pharmacokinetics of single (SAD) and multiple ascending doses (MAD) of SPR741 in healthy volunteers. Poster P2233. In Proceedings of the ECCMID 2018, Madrid, Spain, 21–24 April 2018.
    • (2018) Proceedings of The ECCMID 2018
    • Utley, L.1    Lister, T.2    Coleman, S.3    Eckburg, P.B.4
  • 103
    • 85059890558 scopus 로고    scopus 로고
    • Polymyxin derivatives and their use in different combination therapies together with different
    • Patent Application WO 26 November
    • Brown, P.; Dawson, M.J.; Simonovic, M.; Boakes, S.; Duperchy, E. Polymyxin Derivatives and Their Use in Different Combination Therapies Together with Different. Antibiotics. Patent Application WO 2014/188178, 26 November 2014.
    • (2014) Antibiotics
    • Brown, P.1    Dawson, M.J.2    Simonovic, M.3    Boakes, S.4    Duperchy, E.5
  • 104
    • 85059914646 scopus 로고    scopus 로고
    • Polymyxin derivatives and their use in combination therapies together with different
    • Patent Application WO 18 September
    • Brown, P.; Dawson, M.J.; Simonovic, M.; Boakes, S.; Duperchy, E.; Stanway, S.J.; Wilson, A.; Moss, S.F. Polymyxin Derivatives and Their Use in Combination Therapies Together with Different. Antibiotics. Patent Application WO 2015/135976, 18 September 2015.
    • (2015) Antibiotics
    • Brown, P.1    Dawson, M.J.2    Simonovic, M.3    Boakes, S.4    Duperchy, E.5    Stanway, S.J.6    Wilson, A.7    Moss, S.F.8
  • 108
    • 84987862339 scopus 로고    scopus 로고
    • Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems
    • CrossRef PubMed
    • Rudilla, H.; Fusté, E.; Cajal, Y.; Rabanal, F.; Vinuesa, T.; Viñas, M. Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems. Molecules 2016, 21, 1223. [CrossRef] [PubMed]
    • (2016) Molecules , vol.21 , pp. 1223
    • Rudilla, H.1    Fusté, E.2    Cajal, Y.3    Rabanal, F.4    Vinuesa, T.5    Viñas, M.6
  • 109
    • 84912077873 scopus 로고    scopus 로고
    • Unacylated tridecapeptin A1 acts as an effective sensitizer of Gram-negative bacteria to other antibiotics
    • Cochrane, S.A.; Vederas, J.C. Unacylated tridecapeptin A1 acts as an effective sensitizer of Gram-negative bacteria to other antibiotics. Int. J. Antimicrob. Agents 2014, 44, 493–499. [CrossRef]
    • (2014) Int. J. Antimicrob. Agents , vol.44 , pp. 493-499
    • Cochrane, S.A.1    Vederas, J.C.2
  • 110
    • 85038386394 scopus 로고    scopus 로고
    • Novel linear lipopeptide paenipeptins with potential for eradicating biofilms and sensitizing Gram-negative bacteria to rifampicin and clarithromycin
    • Moon, S.H.; Zhang, X.; Zheng, G.; Meeker, D.G.; Smeltzer, M.S.; Huang, E. Novel linear lipopeptide paenipeptins with potential for eradicating biofilms and sensitizing Gram-negative bacteria to rifampicin and clarithromycin. J. Med. Chem. 2017, 60, 9630–9640. [CrossRef]
    • (2017) J. Med. Chem. , vol.60 , pp. 9630-9640
    • Moon, S.H.1    Zhang, X.2    Zheng, G.3    Meeker, D.G.4    Smeltzer, M.S.5    Huang, E.6
  • 111
    • 0029843859 scopus 로고    scopus 로고
    • Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria
    • Vaara, M.; Porro, M. Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrob. Agents Chemother. 1996, 40, 1801–1805. [CrossRef]
    • (1996) Antimicrob. Agents Chemother. , vol.40 , pp. 1801-1805
    • Vaara, M.1    Porro, M.2
  • 112
    • 84969597463 scopus 로고    scopus 로고
    • Treatment of Gram-negative bacterial infections by potentiation of antibiotics
    • Zabava, T.P.; Pucci, M.J.; Parr, T.R., Jr.; Lister, T. Treatment of Gram-negative bacterial infections by potentiation of antibiotics. Curr. Opin. Microbiol. 2016, 33, 7–12. [CrossRef]
    • (2016) Curr. Opin. Microbiol. , vol.33 , pp. 7-12
    • Zabava, T.P.1    Pucci, M.J.2    Parr, T.R.3    Lister, T.4
  • 114
    • 85041302313 scopus 로고    scopus 로고
    • Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics
    • CrossRef PubMed
    • MacNair, C.R.; Stokes, J.M.; Carfrae, L.A.; Flebig-Comyn, A.A.; Coombes, B.K.; Mulvey, M.R.; Brown, E.D. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat. Commun. 2018, 9, 458–465. [CrossRef] [PubMed]
    • (2018) Nat. Commun. , vol.9 , pp. 458-465
    • MacNair, C.R.1    Stokes, J.M.2    Carfrae, L.A.3    Flebig-Comyn, A.A.4    Coombes, B.K.5    Mulvey, M.R.6    Brown, E.D.7
  • 115
    • 85053899618 scopus 로고    scopus 로고
    • Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae
    • CrossRef PubMed
    • Brennan-Krohn, T.; Pironti, A.; Kirby, J.E. Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae. Antimicrob. Agents Chemother. 2018, 62, e00873-18. [CrossRef] [PubMed]
    • (2018) Antimicrob. Agents Chemother. , vol.62 , pp. e00873-e00918
    • Brennan-Krohn, T.1    Pironti, A.2    Kirby, J.E.3
  • 116
    • 85059896029 scopus 로고    scopus 로고
    • The novel polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
    • Tyrrell, J.M.; Aboklaish, A.F.; Walsh, T.R.; Vaara, T.; Vaara, M. The novel polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. Peptides 2018. [CrossRef]
    • (2018) Peptides
    • Tyrrell, J.M.1    Aboklaish, A.F.2    Walsh, T.R.3    Vaara, T.4    Vaara, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.